Kawasaki Disease: Practice Essentials, Background, Pathophysiology
T. Dorina Papageorgiou Lab
Content
The T. Dorina Papageorgiou - Investigational Targeted Brain Neurotherapeutics Lab has developed a novel, targeted and individualized MRI-compatible brain computer interface (BCI) based on associative learning principles that can induce neuromodulation in patients with neurological sequelae following stroke (commonly a result of a posterior cerebral artery infarct, or a middle cerebral artery infarct), traumatic brain injury or tumor resection.
We call our MRI-BCI, individualized real-time functional MRI neurofeedback (iRTfMRI nFb), which is based on promoting the reorganization of networks by bypassing lesioned pathways and capitalizing on redundant, intact but functionally associated pathways to the injured ones.
This is achieved by modulating the magnitude and spatial extent of Blood-Oxygen-Level-Dependent (BOLD) signal with the goal to recover the brain function, as a result of a neurological insult.
We apply this investigational treatment to patients with impairments of the following cortical systems:
Reorganization is possible by neuromodulating the spatial extent and intensity of the Blood-Oxygen-Level-Dependent (BOLD) signal to a patient's intact cortical area, which takes over in performing the function, as it has been impaired in the primary cortical areas following neurological injury.
This investigational treatment engages associative learning mechanisms that modulate the activity of intact cortical areas with the goal to improve performance in patient populations with neurological sequelae as a result of stroke, traumatic brain injury or tumor resection.
Our goal is to understand how the brain learns, specifically under induced learning conditions. The overall aims of our lab are to study the mechanisms of adaptive plasticity/reorganization of cortical functions using neuroimaging modalities and techniques:

Comments
Post a Comment